ArticleFrontiers in oncology2022

Pseudo-progression with osimertinib after definitive chemoradiation in unresectable epidermal growth factor receptor mutation positive of stage III non-small cell lung cancer: A case report.

Fei Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.